Nicholas D. Oakes

2.7k total citations
36 papers, 2.2k citations indexed

About

Nicholas D. Oakes is a scholar working on Physiology, Molecular Biology and Surgery. According to data from OpenAlex, Nicholas D. Oakes has authored 36 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Physiology, 23 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Nicholas D. Oakes's work include Adipose Tissue and Metabolism (23 papers), Peroxisome Proliferator-Activated Receptors (13 papers) and Metabolism, Diabetes, and Cancer (12 papers). Nicholas D. Oakes is often cited by papers focused on Adipose Tissue and Metabolism (23 papers), Peroxisome Proliferator-Activated Receptors (13 papers) and Metabolism, Diabetes, and Cancer (12 papers). Nicholas D. Oakes collaborates with scholars based in Sweden, Australia and United Kingdom. Nicholas D. Oakes's co-authors include Edward W. Kraegen, Donald J. Chisholm, Gregory J. Cooney, Stuart M. Furler, Bengt Ljung, A. B. Jenkins, Pia Thalén, Carsten Schmitz‐Peiffer, Trevor J. Biden and Allan Watkinson and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Diabetes.

In The Last Decade

Nicholas D. Oakes

35 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicholas D. Oakes Sweden	21	1.3k	1.2k	425	412	324	36	2.2k
Philip D.G. Miles United States	25	1.5k 1.2×	1.1k 0.9×	749 1.8×	513 1.2×	336 1.0×	33	2.7k
Piotr Zabielski Poland	28	1.2k 0.9×	834 0.7×	501 1.2×	249 0.6×	314 1.0×	76	2.1k
Attila Brehm Austria	17	990 0.8×	1.1k 0.9×	576 1.4×	526 1.3×	372 1.1×	19	2.2k
Clemens Fürnsinn Austria	24	1.1k 0.9×	802 0.7×	363 0.9×	444 1.1×	388 1.2×	62	2.0k
Samar I. Itani United States	8	1.1k 0.9×	1.5k 1.2×	989 2.3×	330 0.8×	314 1.0×	8	2.4k
Anthony J. Romanelli United States	8	1000 0.8×	801 0.7×	922 2.2×	639 1.6×	473 1.5×	10	2.2k
Edwin J. Landaker United States	7	1.6k 1.2×	1.5k 1.2×	400 0.9×	209 0.5×	258 0.8×	8	2.5k
Shin Yonemitsu Japan	18	875 0.7×	956 0.8×	646 1.5×	572 1.4×	368 1.1×	35	2.0k
Jonathan P. Stoehr United States	11	1.1k 0.8×	768 0.6×	497 1.2×	294 0.7×	598 1.8×	12	2.2k
Patricia C. Chui United States	10	1.8k 1.4×	929 0.8×	725 1.7×	225 0.5×	225 0.7×	11	2.5k

Countries citing papers authored by Nicholas D. Oakes

Since Specialization

Citations

This map shows the geographic impact of Nicholas D. Oakes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas D. Oakes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas D. Oakes more than expected).

Fields of papers citing papers by Nicholas D. Oakes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas D. Oakes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas D. Oakes. The network helps show where Nicholas D. Oakes may publish in the future.

Co-authorship network of co-authors of Nicholas D. Oakes

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas D. Oakes. A scholar is included among the top collaborators of Nicholas D. Oakes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas D. Oakes. Nicholas D. Oakes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alexandersson, Ida, Stefanie Maurer, Bader Zarrouki, et al.. (2022). Chronotherapy with a glucokinase activator profoundly improves metabolism in obese Zucker rats. Science Translational Medicine. 14(668). eabh1316–eabh1316. 9 indexed citations

Wallenius, Kristina, Lars Löfgren, Maria Sörhede‐Winzell, et al.. (2022). The SGLT2 inhibitor dapagliflozin promotes systemic FFA mobilization, enhances hepatic β-oxidation, and induces ketosis. Journal of Lipid Research. 63(3). 100176–100176. 48 indexed citations

Lindblom, Anna, et al.. (2018). Uptake and tissue accretion of orally administered free carboxylic acid as compared to ethyl ester form of docosahexaenoic acid (DHA) in the rat. PLoS ONE. 13(8). e0201367–e0201367. 7 indexed citations

Andersson, Robert, J.O. Almquist, Mats Jirstrand, et al.. (2017). Modeling of free fatty acid dynamics: insulin and nicotinic acid resistance under acute and chronic treatments. Journal of Pharmacokinetics and Pharmacodynamics. 44(3). 203–222. 8 indexed citations

Wallenius, Kristina, Pia Thalén, Jan‐Arne Björkman, et al.. (2017). Involvement of the metabolic sensor GPR81 in cardiovascular control. JCI Insight. 2(19). 43 indexed citations

Baccega, Tania, et al.. (2016). Nicotinic acid timed to feeding reverses tissue lipid accumulation and improves glucose control in obese Zucker rats[S]. Journal of Lipid Research. 58(1). 31–41. 16 indexed citations

Kjellstedt, Ann, et al.. (2015). Dosing profile profoundly influences nicotinic acid's ability to improve metabolic control in rats. Journal of Lipid Research. 56(9). 1679–1690. 13 indexed citations

Ericsson, Anette, Nigel Turner, Göran I. Hansson, Kristina Wallenius, & Nicholas D. Oakes. (2014). Pharmacological PPARα Activation Markedly Alters Plasma Turnover of the Amino Acids Glycine, Serine and Arginine in the Rat. PLoS ONE. 9(12). e113328–e113328. 9 indexed citations

Wallenius, Kristina, Ann Kjellstedt, Pia Thalén, Lars Löfgren, & Nicholas D. Oakes. (2013). The PPARα/γAgonist, Tesaglitazar, Improves Insulin Mediated Switching of Tissue Glucose and Free Fatty Acid UtilizationIn Vivoin the Obese Zucker Rat. PPAR Research. 2013. 1–14. 20 indexed citations

10.

Nylander, Sven, Bengt Kull, Jan‐Arne Björkman, et al.. (2012). Human target validation of phosphoinositide 3‐kinase (PI3K)β: effects on platelets and insulin sensitivity, using AZD6482 a novel PI3Kβ inhibitor. Journal of Thrombosis and Haemostasis. 10(10). 2127–2136. 102 indexed citations

11.

Camejo, Germán, et al.. (2006). Beyond lipids, pharmacological PPARα activation has important effects on amino acid metabolism as studied in the rat. American Journal of Physiology-Endocrinology and Metabolism. 292(4). E1157–E1165. 43 indexed citations

12.

Oakes, Nicholas D., Pia Thalén, Severina M. Jacinto, et al.. (2005). Tesaglitazar, a dual PPARα/γ agonist, ameliorates glucose and lipid intolerance in obese Zucker rats. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 289(4). R938–R946. 32 indexed citations

13.

Hegarty, Bronwyn D., Stuart M. Furler, Nicholas D. Oakes, Edward W. Kraegen, & Gregory J. Cooney. (2004). Peroxisome Proliferator-Activated Receptor (PPAR) Activation Induces Tissue-Specific Effects on Fatty Acid Uptake and Metabolism in Vivo—A Study Using the Novel PPARα/γ Agonist Tesaglitazar. Endocrinology. 145(7). 3158–3164. 60 indexed citations

14.

Oakes, Nicholas D. & Stuart M. Furler. (2002). Evaluation of Free Fatty Acid Metabolism in Vivo. Annals of the New York Academy of Sciences. 967(1). 158–175. 20 indexed citations

15.

Ljung, Bengt, Krister Bamberg, Björn Dahllöf, et al.. (2002). AZ 242, a novel PPARα/γ agonist with beneficial effects on insulin resistance and carbohydrate and lipid metabolism in ob/ob mice and obese Zucker rats. Journal of Lipid Research. 43(11). 1855–1863. 99 indexed citations

16.

Oakes, Nicholas D., Pia Thalén, Severina M. Jacinto, & Bengt Ljung. (2001). Thiazolidinediones Increase Plasma-Adipose Tissue FFA Exchange Capacity and Enhance Insulin-Mediated Control of Systemic FFA Availability. Diabetes. 50(5). 1158–1165. 155 indexed citations

17.

Furler, Stuart M., et al.. (2000). Local factors modulate tissue-specific NEFA utilization: assessment in rats using 3H-(R)-2-bromopalmitate.. Diabetes. 49(9). 1427–1433. 42 indexed citations

18.

Oakes, Nicholas D., et al.. (1997). The insulin sensitizer, BRL 49653, reduces systemic fatty acid supply and utilization and tissue lipid availability in the rat. Metabolism. 46(8). 935–942. 110 indexed citations

19.

Furler, Stuart M., Nicholas D. Oakes, Allan Watkinson, & Edward W. Kraegen. (1997). A high-fat diet influences insulin-stimulated posttransport muscle glucose metabolism in rats. Metabolism. 46(9). 1101–1106. 18 indexed citations

20.

Oakes, Nicholas D., et al.. (1994). A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat. Diabetes. 43(10). 1203–1210. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact